This article focuses on the various models for kidney toxicity due to trichloroethylene (TCE) and its glutathione-dependent metabolites, in particular S-(1,2-dichlorovinyl)-L-cysteine. Areas of controversy regarding the relative importance of metabolic pathways, species differences in toxic responses, rates of generation of reactive metabolites, and dose-dependent phenomena are highlighted. The first section briefly reviews information on the incidence and risk factors of kidney cancer in the general U.S. population. Epidemiological data on incidence of kidney cancer in male workers exposed occupationally to TCE are also summarized. This is contrasted with cancer bioassay data from laboratory animals, that highlights sex and species differences and, consequently, the difficulties in making risk assessments for humans based on animal data. The major section of the article considers proposed modes of action for TCE or its metabolites in kidney, including peroxisome proliferation, a2u-globulin nephropathy, genotoxicity, and acute and chronic toxicity mechanisms. The latter comprise oxidative stress, alterations in calcium ion homeostasis, mitochondrial dysfunction, protein alkylation, cellular repair processes, and alterations in gene expression and cell proliferation. Finally, the status of risk assessment for TCE based on the kidneys as a target organ and remaining questions and research needs are discussed.
This artide focuses on the various models for kidney toxicity due to trichloroethylene (TCE). In particular, focus will be on the role and quantitative importance of the glutathione (GSH)-dependent (i.e., cysteine conjugate I-lyase [3-lyase] ) pathway in generation of reactive metabolites that have been associated with various cytotoxic and carcinogenic responses to either TCE or to the GSH conjugate S-(1,2-dichlorovinyl)glutathione (DCVG). A major focus will be factors and responses contributing to or leading to renal tumorigenesis, as this topic has been of major interest in human health risk assessment. Areas of controversy will be highlighted, including discussions of species differences in toxic responses and rates of generation of reactive metabolites and dosedependent phenomena. Key metabolites that have been associated with cytotoxic and carcinogenic effects in laboratory animals will be identified, and their relevance to humans will be evaluated.
The first section briefly reviews information on the incidence of kidney cancer in the general U.S. population. Incidence and risk factors for kidney cancer in general are briefly discussed, and then data on incidence of kidney cancer after exposure to TCE are evaluated. Limited epidemiological data are available for renal cancer in humans exposed to TCE. Studies of TCE-induced renal cancer in laboratory animals highlight sex and species differences and, consequently, the difficulties in making risk assessments for humans based on the animal data. The second section will briefly review the toxic and reactive metabolites of TCE that may be important in TCE-induced renal toxicity. The subject of TCE metabolism is dealt with in greater detail in the article on "Metabolism of Trichloroethylene" (1) . The third and major section of this paper considers proposed modes of action for TCE in the kidneys. Several mechanisms are proposed, induding peroxisome proliferation, a2u-globulin nephropathy, genotoxicity, and acute and chronic cytotoxicity. The latter includes oxidative stress, alterations in calcium ion homeostasis, mitochondrial dysfunction, protein alkylation, cellular repair processes, and alterations in gene expression and cell proliferation. Finally, the status of risk assessment for TCE based on the kidneys as a target organ and remaining questions and research needs will be discussed.
Epidemiology of Kidney Cancer
Inddence and Mortality Rats of Kidney Cance in the U.S. Population
This section summarizes data on the incidence of kidney cancer and mortality in the general U.S. population and the health consequences involved. Further, risk factors that may enhance susceptibility to kidney cancer are summarized. The discussion on the general properties of renal neoplasia is summarized from Brenner and Rector's The Kidney, Ffih Edition (2) . Malignant neoplasms involving the renal parenchyma and renal pelvis may be primary or secondary in origin. Primary neoplasms are those that derive from transformation of renal cells, whereas secondary neoplasms are those that derive from metastases of tumors in other tissues. In the kidneys, the frequency of metastatic neoplasms is higher than that of primary tumors. Invasive disease accounts for 99% of all tumors. Renalcell carcinoma accounts for approximately 85% of all primary renal neoplasms. Primary neoplasm of the renal pelvis or ureter accounts for 7-8% of renal neoplasms; nephroblastoma (Wilms tumor) accounts for 5-6% of the total; various sarcomas of renal origin account for the remainder of the primary tumors. Incidence rather than mortality is a better indicator of kidney cancer, since survival (5-years) is 58% for males and females combined for invasive disease; no differences in survival between sexes have been observed (3, 4) . Survival is even higher, 87%, for localized disease (4) . Generally, the primary treatment for kidney cancer is surgical removal of the diseased kidney. It is rare that both kidneys are affected, and individuals can function quite well with one kidney. Renal-cell carcinoma is characterized by diverse and often obscure symptoms and may easily be mistaken for other diseases.
Controversy still exists about the relationship between renal-cell carcinoma and renal adenoma, as the two are not readily distinguishable on the basis of gross histologic, immunologic, or ultrastructural features. Both types of cells arise from the proximal convoluted tubules. However, renal adenomas are typically incidental findings at autopsy, usually as small, well-circumscribed lesions of the renal cortex, and renal adenocarcinomas are usually larger lesions.
Estimates for new cases of primary kidney cancer and other urinary cancer cases for males and females combined for 1996 and 1997 are 36,000 and 28,800, respectively, with 12,000 and 11,300 deaths, respectively (5, 6) . Incidence and mortality rates for cancer as the primary kidney disease (kidney and renal pelvis combined, since data are not available for a specific subsite) for the most recent time period are for 1995. In 1995, the age-adjusted incidence rate was 9.2 per 100,000, with rates in males twice those of females (4) . Incidence has been increasing over time, with the increase in nonwhites much greater than in whites (4) . Mortality rates reflect the same pattern as incidence; however, rates are lower due to relatively good survival. The age-adjusted mortality rate in 1995 was 3.6 per 100,000, and showed a gradual increase over the past 20 years (4). The increasing mortality among nonwhites over time was greater than that among whites (4) . Recent analysis of the National Cancer Database (3) suggests that kidney cancers are being diagnosed at an earlier stage of the disease and with greater precision.
Risk Factors
A number of risk factors have been identified within recent years for renal-cell carcinoma in one national and one international multicenter case-control study. The focus of this discussion is on renal-cell carcinoma, since it is the most predominant form of kidney cancer. Risk factors are primarily hypertension status, diet, family history, and personal lifestyle factors. Occupational factors have been subject only to limited study; most studies do not uniquely identify specific chemical exposures. Renal-cell cancer is not usually considered an occupationally related cancer, as are lung and bladder cancer (7) .
In the latter cases, exposures are assessed according to job category or class of agent. The epidemiologic evidence examining TCE exposure, specifically, will be discussed in the next section.
The strongest evidence for which a causal association can be inferred is between renal-cell carcinoma and smoking. Statistically significant elevated risks for renal-cell carcinoma have been consistently reported in several studies (8) (9) (10) (11) with cigarette smoking. Risks increased with increasing duration and number of cigarettes (pack-years), adding further support for a causal association. As with other smoking-related cancers, risk is reduced among long-term former smokers. One other study (12) additionally reports an association between cigarette smoking and carcinoma of the renal pelvis and ureter. McLaughlin et al. (7) estimate that between 24 and 30% of all renal cancer deaths are attributable to smoking.
Associations between renal-cell carcinoma and other etiologic agents are more variable and less definitive than those for cigarette smoking. Limited data suggest that long-term use of phenacetin-containing analgesics is associated with an increased renal-cell carcinoma risk (13) (14) (15) (16) . Abuse of analgesics containing phenacetin has been causally associated with renal pelvis and ureter cancer (17) . Having a relative with a previous diagnosis of renal-cell carcinoma has been identified in two studies (7, 10) . Not unexpectedly, a past history of kidney stones or kidney disease is also associated with renal-cell carcinoma, although these observations may be biased due to differential recall of past kidney disease between cases and controls (7). Limited evidence exists for an association between the use of diuretics and other antihypertensive agents and renal-cell carcinoma (18) (19) (20) (21) (22) . Additionally, a history of hypertension has been identified as another risk factor (21) . Hypertension, diuretic use, and taking antihypertensive medication are highly correlated, making it difficult to identify which factors may be more important. Three recent studies (9, 23, 24) provide support for the hypothesis that diets high in meat or fried meats are associated with an increase in risk for renal-cell cancer and that diets high in vegetable and fruit content are protective. Body mass index was found to be a risk factor among females, and to a lesser extent, among males, with rate of weight change appearing as an independent risk factor (25) . Last, fairly consistent findings have been reported for a modest, positive association between the number of births and risk for renal-cell carcinoma and a protective effect with use of oral contraceptives (26) (27) (28) .
Only now are the human studies taking a more serious examination of possible associations between renal-cell carcinoma and occupational exposures. Most information on occupation comes from case-control studies where exposure is only crudely characterized. Associations between kidney cancer and occupational exposures or job categories that have been reported in at least one study are the following: truck drivers and those exposed to gasoline (22, 29, 30) ; employment in the iron or steel industry (31) ; with exposure to gasoline (29) (30) (31) (32) , aviation fuel (33), or other petroleum products (31); insecticides or herbicides (22) ; asbestos (31) ; cadmium (31) ; and dry-cleaning solvents (31) . The large case-control studies are adequate for raising hypotheses regarding possible associations; however, they are severely limited when they are used alone to support statements regarding possible causal associations.
Cohort studies of petroleum workers have not reported elevated risks with kidney cancer. (34) . Alternatively, case-control studies of kidney cancer are not as consistent; two case-control studies report associations with gasoline exposure (31, 32) , whereas a recent case-control study of kidney cancer nested among male petroleum workers did not show any associations with exposure to petroleum hydrocarbons (35) (50) (51) (52) where no elevations in kidney cancer risks were noted, and the two case-control studies reported divergent results. IARC (49) noted that a study of male German cardboard manufacturing workers exposed to TCE (53) (53) presented, for the population studied, standardized incidence rates (SIR) for kidney cancer, using rates from the Danish Cancer Registry and from the former German Democratic Republic as comparisons. For each comparison, a statistically significant elevation in the SIR for kidney cancer was noted. IARC (49) considered these findings to be a cluster and concluded that kidney cancer among these male workers needed further study. The report of Henschler et al. (53) has spurred much controversy (54) (55) (56) ; even if the workers studied represent a cluster, this warrants further study since several human carcinogens were first recognized through cluster investigations.
Two other reviews (57, 58) (68) (69) (70) (71) (72) (73) .
In a National Toxicology Program (NTP) bioassay, groups of 50 male and 50 female rats were administered 0, 500, or 1,000 mg/kg/day high-purity TCE by gavage in corn oil vehicle 5 days a week for up to The survival of all treated groups was significantly lower than that of controls. Oral administration of TCE in this study was associated with an increased incidence of renal tubular-cell adenomas and adenocarcinomas. Because of reduced survival, toxicity, and deficiencies in conduct of the study, however, the NTP concluded that the study was inadequate for assessing either the absence or presence of carcinogenicity, although they reviewed the results as indicating renal toxicity in all tested rat strains, including the Fischer 344 (F344) rat studied in their 1986 bioassay. There was no difference in kidney toxicity between males and females of any strain. The histopathologic evaluations of the kidneys of all five strains of rats have been summarized (72) (73) (74) (75) . The toxic nephropathy observed in these studies clearly does not present as the spontaneous lesion occurring in aging rats. Rather, the lesions are characterized by cytomegaly, karyomegaly, and toxic nephrosis of the tubular epithelial cells in the inner renal cortex. These lesions were not observed in control animals. Severity of cytomegaly was found to be proportional to duration of dosing as observed in animals that died early. The 1990 NTP report describes a statistically significant increase in renal adenomas in male Osborne-Mendel rats and the increase in renal adenocarcinomas in F344 rats previously reported in the 1988 bioassay report. Five of the six renal adenomas in lowdose male Osborne-Mendel rats occurred among the 17 rats alive at the end of the study. One rare renal tubular-cell adenocarcinoma was seen in a high-dose male OsborneMendel rat in this study. The NTP also noted the finding of one rare tubular-cell adenocarcinoma in a male Osborne-Mendel rat in a previous study (70) .
Henschler et al. (68) administered pure TCE (stabilized by an amine base) by inhalation at 0, 100, and 500 ppm for 6 hr/day, 5 days per week, for 18 Although the kidney tumor increases in male rats are not all statistically significant, the findings are generally considered to be biologically significant and important in an assessment of potential human hazard because renal tumors in rats are rare. That is, such tumors are not often seen in large numbers of historical control animals. In some instances, however, chemically induced male rat kidney tumors are species-and genderspecific and, therefore, of little importance in human hazard evaluation. Thus, of particular interest is the objective of the analysis presented in this paper to focus attention on available data that address whether TCEinduced male rat kidney tumors may be the result of mechanisms or a mode-of-action operative, in theory, in humans.
Based on the above-mentioned long-term carcinogenicity studies, both Goeptar et al. (76) and Briuning et al. (63) have suggested that chronic cellular injury is a necessary prerequisite for production of renal tumors. In a study of hospital patients diagnosed with renal-cell cancer, those who had previous, documented exposure to TCE had evidence of average to severe tubular damage at higher rates than those who had no previous exposure to TCE (63) .
The issue of nephrotoxicity and chronic cellular injury in relation to development of renal tumors deserves further comment. It is clear from the studies in rodents that renalcell tumors do not occur in the absence of some kidney damage. The kidneys are highly susceptible to damage due to their high blood flow and the presence of myriad transport mechanisms that allow renal epithelial cells, particularly those of the proximal tubule, to concentrate bloodborne and filtered chemicals to high intracellular levels. Moreover, renal epithelial cells contain a large array of bioactivating enzymes, both those that are similar to the xenobioticmetabolizing enzymes in the liver and those that are unique to the kidneys, that metabolize chemicals to reactive and toxic species (77, 78) . Although one can conclude that the kidneys are a minor target organ in vivo and that risk is low, because the incidence of renal tumors is typically low, the incidence of nephrotoxicity is much higher. The hypothesis of Goeptar et al. (76) and Briining et al. (63) suggests further that the injury is followed by induction of repair processes, which then leads to cellular proliferation. However, if the extent of the nephrotoxicity is greater, renal cells will be irreversibly injured and the tissue will not be capable of activating repair processes. In that case, then, cellular proliferation and carcinogenesis will not be observed, and the risk based on tumor incidence will be underestimated.
In the sections that follow, potential biochemical mechanisms or modes of action of TCE in producing renal-cell cancer will be discussed.
Toxic and Reactive Metabolites of TCE That May Be Important in Renal Toxicity of TCE Oxidative Pathway ofTCE Metabolism TCE is metabolized by two general metabolic pathways, an oxidative pathway whose initial step is catalyzed by cytochrome P450 (P450), and a GSH-dependent pathway whose initial step is catalyzed by GST. Key oxidative metabolites that may be associated with toxicity and tumorigenesis indude trichloroacetate (TCA), dichloroacetate (DCA), and chloral hydrate (CH). Although formation of these metabolites by P450 and other oxidative enzymes has generally been emphasized in considerations of hepatic metabolism and liver injury, renal proximal tubular cells also possess many of the same isoforms of P450 that are found in the liver parenchymal cells, including CYP2E1, which is the primary isoform believed to catalyze oxidation of TCE (79, 80) . Hence, these metabolites can be formed by renal enzymes and may play some role in TCE-induced renal injury.
Little investigation into the role of P450-derived metabolites of TCE in TCE-induced renal injury has been undertaken. It Hence, from these studies we can condude that a) if renal levels of accumulation of TCA from TCE are similarly lower than hepatic levels of accumulation of TCA as was found for PER, then peroxisome proliferation is unlikely to be important in the kidney for TCE; and b) renal peroxisomes are generally less responsive to peroxisome proliferators than hepatic peroxisomes, which also makes a role for peroxisome proliferation in TCEinduced nephrocarcinogenicity unlikely.
As for the third issue, there has been much debate about the significance of peroxisome proliferation in human liver. A prevailing view is that peroxisome proliferation is likely to be largely a rodent-specific response, with primate species including man being markedly less responsive to drug-induced peroxisome proliferation than rodents, and that peroxisome proliferation either does not occur or occurs to much a smaller extent in humans (97, 98 Furthermore, Melnick (101) proposed that the accumulation of ac2u in kidneys of male rats due to exposure to certain halogenated hydrocarbons and the consequent nephropathy and induction of cellular proliferation do not explain the male rat-specific nephrocarcinogenicity of these chemicals. Rather, Melnick (101) suggested that by binding halogenated hydrocarbons, a2u may act as a transport protein to increase delivery of the hydrocarbon to the target tissue. The paper by Melnick (101) generated some controversy, as it contrasted directly with the mechanism proposed by Lehman-McKeeman et al. (99) and others. In response to Melnick's proposed alternative mechanism, the proponents of the generally accepted mechanism published a commentary (102) arguing that no experimental evidence exists to support the alternative mechanism and that the widely accepted mechanism of a2u-mediated renal injury is supported. They additionally emphasized that the decision of the U.S. Environmental Protection Agency (U.S. EPA) to accept the widely accepted mechanism allowed them to appropriately conclude that the (X2u phenomenon is largely male rat specific and is not relevant to humans. Melnick (103) replied that there is evidence for an alternative mechanism of action and recommended that rather than conclude that this process is irrelevant to humans, one should conclude that species differences in transport and disposition of chemicals alters delivery of toxic chemicals to the target organ. He emphasized that functionally analogous proteins to ct2u are present in humans.
Nonetheless, the prevailing view is that the (X2u hypothesis is male rat specific and that this mechanism is not relevant to humans (104) . The a2u found in male rats is structurally related to a group of transport proteins, many of which are found in humans. (131) found that both DCVG and DCVC administered to male F344 rats by intraperitoneal injections in isotonic saline resulted in elevations in BUN and urinary glucose excretion. Furthermore, inhibition of renal GGT activity with acivicin protected rats from DCVG-induced nephrotoxicity. In addition, both the ,-lyase inhibitor AOAA and the renal organic anion transport inhibitor probenecid provided protection from DCVC, demonstrating a requirement for metabolism of DCVG to the cysteine conjugate by the action of renal GGT and dipeptidase, uptake into the renal cell by the organic anion transporter, and subsequent activation by the I-lyase. This conclusion was supported further by showing that the a-methyl analog of DCVC, which cannot undergo a P-elimination reaction due to the presence of the methyl group, was not nephrotoxic.
Darnerud et al. (132) showed similar findings in female C57BL mice, using covalent binding of radiolabeled DCVC to acidinsoluble renal tissue and histopathology as measures of nephrotoxicity. GSH depletion or addition of probenecid diminished DCVC covalent binding and nephrotoxicity, indicating a role for oxidative stress and organic anion transport in DCVC-induced nephrotoxicity (see below).
Several studies on the isomeric specificity of DCVC-induced nephrotoxicity showed that the L-isomer is more potent than the D-isomer (133, 134) and that the 1,2-isomer is more potent than the 2,2-isomer (135). These results are consistent with the known enzymology of DCVC bioactivation and with the isomer specificity studies on DCVCinduced mutagenicity described above.
Acute cytotoxicity: in vitro studies. Chakrabarti and Tuchweber (127) showed that accumulation of aminohippurate by renal cortical slices, which is often used as an indicator of proximal tubular function, was inhibited at 24 hr after intraperitoneal administration of 22 mmol TCE/kg to male F344 rats.
In addition to the higher susceptibility of male rats to TCE-induced nephrocarcinogenicity and nephrotoxicity, isolated renal cortical cells from male F344 rats are more susceptible to acute cytotoxicity from TCE than cells from female rats. As shown in Figure 1 , TCE caused a modest increase in lactate dehydrogenase (LDH) release from male rat kidney cells but had no significant effect on LDH release from female rat kidney cells. Similar, although more pronounced effects were observed with PER ( Figure 1C,  D) . PER, which differs from TCE only by the presence of a fourth chlorine atom, undergoes bioactivation reactions similar to TCE, forming a GSH conjugate that through subsequent renal metabolism yields a nephrotoxic and nephrocarcinogenic reactive species (136, 137) . Hence, the results from the in vitro model system on sex dependence of susceptibility to TCE and PER agree with the in vivo data.
In contrast to these results with the parent compounds, kidney cells from male rats (81, 138) , or an established renal cell line (139) incubated with DCVG or DCVC exhibit much greater amounts of LDH release than the parent compounds. Moreover, as shown in Figure 2 , DCVC-induced cytotoxicity is modestly higher in kidney cells from male rats compared to female rats, although the dose-response relationship is rather complex. Hence, the same general sex dependence of susceptibility that was observed for the parent compound is observed for the penultimate, cytotoxic metabolite.
Preparations of renal tissue from the rabbit have also been used as in vitro models by some groups to study cysteine conjugateinduced nephrotoxicity. In general, the rabbit kidney cells or tubules seem to exhibit similar sensitivities to DCVC as those from the rat. Wolfgang et al. (140) found that DCVC was rapidly taken up by cortical slices from rabbit kidney and within 1 hr 40% of the DCVC was covalently bound to the tissue. Toxicity was evidenced by release of brush-border membrane enzymes (GGT, alkaline phosphatase) during the first 4 hr after exposure and by histopathology and electron microscopy. Within 4-8 hr, necrosis of the S3 segments of the proximal tubules was evident, and this progressed by 12 hr to encompass all segments of the proximal tubule. Mitochondrial and brush-border membrane damage were evident biochemically within less than 1 hr and morphologically by 6 hr. Irreversible cellular injury was concluded to occur within 30 min. In two similar studies in suspensions of proximal tubular fragments from rabbit kidney, Hassall et al. (141) and Groves et al. (142) showed that DCVC produced the same types of effects as seen in kidney slices. Hassall et al. (141) also demonstrated an important role for tubular cell concentrations of GSH in modulating the ability of DCVC to inhibit tubular active transport, suggesting a role for oxidative stress as a mode of action for DCVC (see below). Groves et al. (142) also compared the cytotoxicity of DCVC with that of a nephrotoxic haloalkyl cysteine conjugate, TFEC, and found, similar to the mutagenicity studies described above, that haloalkenyl cysteine conjugates with chloride-leaving groups are more potent than haloalkyl cysteine conjugates with only fluoride-leaving groups.
Validation of the primary role of the 3-lyase in the bioactivation and cytotoxicity of DCVG and DCVC in human kidney is supported by the purification of the enzyme activity from human kidney cytosol (143) and the characterization of DCVG-and DCVC-induced cytotoxicity in primary cultures of proximal tubular cells from human kidney (144 The discussion in the article on "Metabolism of Trichloroethylene" (1) of DCVC as being a branch point in the metabolism of TCE by the GSH pathway is relevant to an understanding of TCE-induced renal toxicity. DCVC can either undergo N-acetylation to produce the mercapturate, N-acetyl-
which is excreted in the urine, or it can be bioactivated by the f3-lyase or other enzymes to form reactive species that produce toxicity. Additionally, NAcDCVC can be deacetylated within renal proximal tubular cells to regenerate DCVC. The toxicological significance of this was demonstrated in studies that showed that both NAcDCVC and DCVC are toxic in vivo and to in vitro renal preparations (156, 157) . A scheme summarizing these alternative fates ofDCVC is shown in Figure 3 .
The ability of other enzymes besides the 3-lyase, such as the L-cL-hydroxy (L-a-amino) acid oxidase (HAO) and the flavin-containing monooxygenase (FMO) cysteine conjugate S-oxidase (S-oxidase), to bioactivate DCVC is discussed in detail in the article on "Metabolism of Trichloroethylene" (1 (138, 142, 158, 159) by showing that alterations in 3-lyase activity, such as inhibition with AOAA or stimulation with 2-keto acids, correspondingly alters DCVC toxicity. In spite of the undisputed importance of the ,B-lyase in cysteine conjugate-induced nephrotoxicity, several studies have provided evidence that additional enzymatic activities can bioactivate DCVC and other haloalkenes and haloalkanes and lead to toxicity. In two studies on the immunohistochemical localization of the 13-lyase in the renal tubular epithelium, some discrepancies were noted between enzyme localization and the specific renal cell population that was most susceptible to cysteine conjugate-induced injury. Although MacFarlane et al. (160) showed a correspondence between the nephron segments primarily involved in the P elimination of DCVC and TFEC and those most susceptible to HCBD-induced cellular necrosis, Jones et al. (161) found that distribution of the ,3-lyase activity within the proximal tubules did not correspond with the nephron segment that was the most sensitive to DCVC and PCBC.
Although some role for the HAO in DCVC bioactivation is supported by in vitro experimental data (162, 163) , this pathway functions only in the rat, since the enzyme activity is absent from the kidneys of most mammalian species, including humans. Stronger evidence exists for a role for the S-oxidase. Several studies have demonstrated that DCVC sulfoxide (159, 164) and other sulfoxides of cysteine conjugates or mercapturates (165) (166) (167) are more potent nephrotoxicants than the corresponding cysteine conjugates. The presence of the S-oxidase activity in human kidney has not been studied yet, but identification of the activity as possibly catalyzed by FMO1A1 (168) CVC~~i n Urine (138, 174, 176) , severe mitochondrial damage (177) , poly(ADP)-ribosylation of nuclear proteins and DNA double-strand breaks (124) , and changes in cytoskeletal protein structure and plasma membrane blebbing (171, 177 (124, 138, 174, 177) .
The changes in cellular function that occur as a consequence of the changes in Ca2+ ion distribution may be attributed, at least in part, to the activation of Ca2+-dependent degradative enzymes, such as proteases, endonucleases, and phospholipases. The critical importance of Ca2+ ion homeostasis, and the data that clearly show early effects of DCVC metabolites, suggest an important role for disturbances in Ca2+ ion homeostasis in the biochemical mechanism of action of DCVC.
Mitochondrial dysfunction. The mitochondria were implicated a number of years ago as a primary target site within the cell for nephrotoxic cysteine S-conjugates such as DCVC. Parker and colleagues (178) (179) (180) utilized rat liver mitochondria for their pioneering investigations on the mitochondrial toxicity of DCVC with the thinking that even though the liver is not affected by administration of DCVC, isolated liver mitochondria can be obtained more easily and in greater quantities and are typically more functionally intact than isolated kidney mitochondria. Although these points are true, it should not be taken a priori that responses seen in liver and kidney mitochondria will be the same. Furthermore, by use of liver mitochondria as a model system, the impression is created that this is a normal in vivo target site, which is incorrect. As discussed in the section on interorgan metabolism in the article on "Metabolism of Trichloroethylene" (1), the liver cannot take up GSH conjugates and has efficient means for secretion of GSH, cysteine, and N-acetylcysteine conjugates into bile or plasma. Hence, liver mitochondria will not be exposed to DCVC nor will they exhibit diminished function as a consequence of exposure to DCVC, even though the liver does have f-lyase activity.
More recently, several studies on the mechanism of action of DCVC and related cysteine conjugates have focused on the mitochondria and have shown that mitochondrial dysfunction is an early event in the course of exposure to these compounds that may be causally associated in many cases with cellular injury (138, 173, 174, 181 (81, 174, 182, 183) . Experiments on the coupling site specificity of the inhibition of mitochondrial respiration showed that site II, the succinate dehydrogenase complex, is the most susceptible to DCVC (138, 173, 174) and that this is related to inhibition of the enzyme (174, 175) . Formation of covalent adducts with proteins and other macromolecules in mitochondria have been documented (182, 184, 185) . Some of the covalent binding to mitochondrial proteins occurs through formation of mixed disulfides (182) , although other nucleophilic sites are also targeted. Covalent binding of DCVC is largely dependent on its metabolism by the P-lyase, as AOAA blocks much of the binding. The fraction of mixed disulfides as opposed to adducts through other nucleophilic groups, such as the £-amino group of lysyl residues, differs with different cysteine conjugates, indicating that the chemical nature of the reactive metabolite from various cysteine conjugates also differs. The correlation between covalent binding and mitochondrial dysfunction also does not clearly correspond with the extent of metabolism (182) . Hence, it is likely that formation of covalent adducts with mitochondrial proteins is only one mode of action.
The mitochondrial genome is another potential target of nephrotoxic cysteine conjugates (186) , where cysteine conjugates inhibit macromolecular synthesis and produce DNA damage.
Protein alkylation. In addition to mitochondrial proteins that are alkylated by reactive metabolites of DCVC and other cysteine conjugates, cytosolic proteins have been identified as specific targets. Eyre et al. (187) found that both TCE and DCVC, administered in vivo, produced acid-labile adducts with protein. Pretreatment with either diethylmaleate, which depletes cellular GSH content, or the 3-lyase inhibitor AOAA inhibited adduct formation with TCE, indicating that most of the renal adduct formation from TCE was due to metabolism by the GSH conjugation pathway and not by P450. In a companion study (188) , they also showed that whereas the extent of metabolism and covalent binding in mice was greater than in rats, it is the rats that are more sensitive to TCE-induced nephrotoxicity. However, rates of cell replication were correspondingly higher in mice. Hence, they concluded that other factors besides covalent adduct formation must contribute to the induction of renal carcinogenesis by TCE.
It is often difficult to associate the finding of covalent adducts with proteins and functional changes in the cell. However, Lock and Schnellmann (189) identified cytosolic glutathione reductase and mitochondrial lipoyl dehydrogenase from rat renal cortex as specific targets of reactive species generated from f-lyase-dependent metabolism of DCVC.
Chen et al. (190) and Bruschi et al. (191) showed that one consequence of alkylation of cellular macromolecules by metabolites of cysteine conjugates is the transcriptional activation of stress proteins, such as the 70-kDa and 60-kDa heat shock proteins (hsp70 and hsp60). Hence, covalent adduct formation can lead to regulatory changes in the renal cell. In another study from Stevens and colleagues (144), DCVG and DCVC were shown to form covalent adducts with proteins from human proximal tubular cells. Thus, the same biochemical mechanisms observed in rodent kidney cells also occur in the human kidney.
Renal repair processes. A potential response to perturbations caused by exposure to cytotoxic agents is the induction of repair processes. One repair response to agents that form adducts with or damage DNA is the induction of UDS (122, 123) . Wallin et al. (192) observed changes in expression of certain cellular proteins after DCVC-induced cellular injury and the induction of nephrogenic repair. Cytokeratins are characteristic marker proteins that are expressed in normal, differentiated renal proximal tubular cells and other differentiated epithelial cells. After cellular regeneration begins, expression of cytokeratins decreases and expression of vimentin, which is normally characteristic of endothelial cells, increases. Corresponding with this change in expression is an increase in DNA synthesis as cellular proliferation occurs. In a study by Ward et al. (193) of vimentin expression in the kidneys of both control and nephrotoxicant-treated male rats of various ages and in human renal-cell carcinomas, increased vimentin expression was noted in regenerating renal tubular lesions of toxicanttreated rats and in most human renal-cell carcinomas and latent preneoplastic or neoplastic renal tubular lesions that were found incidentally at autopsy. Hence, the repair-proliferation response also occurs in human kidney and is associated with both regeneration after toxicant damage and in development of neoplasias.
Schnellmann and colleagues (194) (195) (196) have developed and validated an in vitro model of renal proximal tubule regeneration using primary cultures of proximal tubular cells from rabbit kidney. From these and the studies described above, it is clear that DCVC can induce damage that leads to a repair response. This repair response is characteristic of renal tissue in both rodents and humans and is therefore relevant to a consideration of human exposure to TCE.
Alterations in gene expression and cell proliferation. Another aspect of the repair and proliferative responses to nephrotoxicants or neoplasia is changes in gene expression that can occur and that may underlie these responses. In addition to demonstrations that DCVC induces renal-cell repair and proliferation (188, 192) , activation of specific genes that have been associated with regulation of cellular growth and differentiation, such as hsp60 and hsp70 (190, 191) , c-fos and c-myc (197, 198) , and gadd 153 (growth arrest and DNA damage) (199) , have been found. Hence, these data show that reactive metabolites generated from DCVC metabolism can alter the expression of critical genes that are involved in the control of cell growth and differentiation. A detailed dose-and time-dependence study of these responses in relation to other effects of DCVC has not, however, been performed. It is thus difficult to assess the relevance of these effects with respect to exposure to TCE. From the available data, one can conclude that exposure of renal cells to high doses of DCVC will produce oxidative stress, protein and DNA alkylation, and mitochondrial dysfunction. As a consequence of inhibition of active transport processes and marked ATP depletion, cytotoxicity will occur and result in acute tubular necrosis. At lower doses, in contrast, it is likely that mild changes in mitochondrial function and oxidative stress as well as selective alkylation of protein and DNA will occur, and that these effects will lead to changes in homeostatic processes in the cell that will ultimately alter gene expression and cell growth. A task for investigators will be to delineate the conditions under which the various responses can occur.
Contribution ofDifferent Modes of

Questions and Research Needs Renal Concentration ofToxic Metabolites
Better methods are needed to quantitate reactive species that are generated during TCE metabolism, particularly in the 1-lyase pathway. This will also improve utility of in vitro studies by allowing more accurate comparisons of in vivo and in vitro studies and will help in the validation of PBPK models. Urinary excretion of mercapturic acids has been used as a marker for the function of the P-lyase pathway, indeed as a marker of exposure (200) . However, many investigators have misused this information to make conclusions regarding the flux through the -lyase pathway relative to that through the P-450 pathway, stating that the relative flux through Figure 4 . Summary scheme of the postulated modes of action of TCE via the GSH conjugation pathway for nephrotoxicity and nephrocarcinogenicity. The scheme summarized demonstrated and hypothesized modes of action of TCE in mammalian kidney, showing the various intracellular targets and the interplay between them in ultimately causing nephrotoxicity or nephrocarcinogenicity. Abbreviations used: DP, dipeptidase; RS-, reactive thiol and subsequent species generated from 3-lyase-catalyzed metabolism of DCVC. The most recent biochemical data on TCE and similar aliphatic hydrocarbons such as PER that are being obtained by various investigators need to be correlated with cancer data to determine if correlations between biochemistry and toxic responses can be made. Although this has been done to some extent, additional studies are needed. As discussed above, the different modes of action in the kidney, which range from cytotoxicity to DNA damage to alterations in gene expression and stimulation of proliferation, should be viewed as a continuum. Dose dependencies for these various responses need to be determined and correlated with tumor incidence and susceptibility in male and female rodents and humans.
Human GSH STransferase Activity for Conjugation with TCE These data will allow more complete assessment of the quantitative importance of this pathway in humans and will allow better comparisons between data from laboratory animals and those from humans. Data are currently available for this pathway in cultured human hepatocytes and human liver and kidney cytosol and microsomes [see article on "Metabolism of Trichloroethylene" (1) and Lash et al. (201) ]. Complete assessment of these results will allow a true, quantitative comparison of metabolic rates in kidney and liver from humans and rodents.
Pharmacokinetic and biochemical study of blood and urine from human volunteers exposed to TCE by inhalation showed that DCVG can be detected in the blood, demonstrating function of at least the first step of the GSH conjugation pathway in humans (202) and, hence, to determine the overall flux of TCE through this pathway. The primary method for quantifying flux through the ,-lyase pathway has been measurement of mercapturates. However, as discussed above, several competing reactions occur whose rates we currently do not or cannot accurately determine. The presence of deacetylation reactions further complicates the situation and makes the interpretation of mercapturate formation less clear. The key rates to be determined, therefore, are those for the P-lyase, the N-acetyltransferase, and the deacetylation reaction. Green et al. (208) have reported that in human kidney, metabolism by the N-acetyltransferase is two orders of magnitude greater than that by ,-lyase.
However, the rates of DCVG formation reported by Green et al. (208) in rodents and in human tissue are more than two orders of magnitude lower than those reported by Lash et al. (81, 82) . Hence, continued research in this area is clearly warranted.
Studies with the chemically related compound PER (203), as discussed above, suggest that the biotransformation rate of PER by the f-lyase pathway is significantly higher in rats than in humans. The authors concluded that use of rat tumorigenicity data for human health risk assessment of PER may overestimate human tumor risks. A second study (209) examined the formation of protein adducts in kidney, liver, and blood of rats, and in human blood after PER inhalation and found much lower levels of adducts in human blood than in rat blood, again suggesting that toxicity is greater in rats than in humans.
Role of Renal Cytochrome P450 analysis and comparison of VHL mutational spectra, therefore, in TCE exposed and non-TCE-exposed cases of renal cell carcinoma is warranted to allow a full and accurate appraisal of the biological significance of this mode of action.
